SLC is targeting high barrier non-penem drug candidates. These non-penem products will leverage SLC's expertise in sterile crystallization and the aseptic processing of sterile powder. Moreover, SLC is also expanding to oral formulation business.

Our pipeline includes but is not limited to:

Product Name

Supplied Product Type


Sterile Paliperidone Palmitate API

Sterile API

Treatment of schizophrenia

SLC-028/ SLC-030

Finished Dosage Form (Injection)

Inhibition of premature LH surges


Finished Dosage Form (Tablet)

Treatment of chronic idiopathic constipation (CIC)